BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🦁 European clinical guidelines for hyperkinetic disorder – first upgrade
12 auth. E. Taylor, M. Döpfner, J. Sergeant, P. Asherson, T. Banaschewski, J. Buitelaar, ... D. Coghill, M. Danckaerts, A. Rothenberger, E. Sonuga-Barke, H. Steinhausen, A. Zuddas
9 2004
9
🦁
🐜 The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes
61 auth. K. Brookes, Xiaohui Xu, Wai Chen, K. Zhou, B. Neale, N. Lowe, R. Aneey, Barbara Franke, M. Gill, J. K. Buitelaar, Pak C. Sham, Desmond Campbell, Joanne Knight, P. Andreou, M. Altink, ... R. Arnold, Frits Boer, C. Buschgens, L. Butler, Hanna Christiansen, Liat Feldman, K. Fleischman, E. Fliers, R. Howe-Forbes, Abigail Goldfarb, A. Heise, I. Gabriëls, Isabelle Korn-Lubetzki, R. Marco, S. Medad, R. Minderaa, F. Mulas, U. Müller, A. Mulligan, Karina Rabin, Nanda N. J. Rommelse, V. Sethna, Jean Sorohan, H. Uebel, L. Psychogiou, A. Weeks, R. Barrett, I. Craig, T. Banaschewski, E. Sonuga-Barke, J. Eisenberg, J. Kuntsi, I. Manor, P. McGuffin, A. Miranda, R. Oades, R. Plomin, Herbert Roeyers, A. Rothenberger, J. Sergeant, H. Steinhausen, E. Taylor, M. Thompson, S. Faraone, P. Asherson, L. Johansson
9 2006
9
🐜
🐜 The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
13 auth. M. Danckaerts, E. Sonuga-Barke, T. Banaschewski, J. Buitelaar, M. Döpfner, C. Hollis, P. Santosh, A. Rothenberger, J. Sergeant, H. Steinhausen, ... E. Taylor, A. Zuddas, D. Coghill
8 2009
8
🐜
🐢 European guidelines on managing adverse effects of medication for ADHD
23 auth. John G. I. Graham, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, Regina Dittmann, M. Döpfner, Robert M. Hamilton, C. Hollis, M. Holtmann, ... M. Hulpke‐Wette, M. Lecendreux, E. Rosenthal, A. Rothenberger, P. Santosh, J. Sergeant, E. Simonoff, E. Sonuga-Barke, E. Sonuga-Barke, I. Wong, A. Zuddas, H. Steinhausen, E. Taylor
8 2010
8
🐢
🐜 Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
22 auth. E. Sobanski, T. Banaschewski, P. Asherson, J. Buitelaar, Wai Chen, B. Franke, M. Holtmann, B. Krumm, J. Sergeant, E. Sonuga-Barke, ... A. Stringaris, E. Taylor, R. Anney, R. Ebstein, M. Gill, A. Miranda, F. Mulas, R. Oades, H. Roeyers, A. Rothenberger, H. Steinhausen, S. Faraone
8 2010
8
🐜
🐜 International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions
14 auth. S. Kutcher, M. Aman, Sarah J. Brooks, J. Buitelaar, E. Daalen, J. Fegert, R. Findling, S. Fisman, L. Greenhill, M. Huss, ... V. Kusumakar, D. Pine, E. Taylor, S. Tyano
8 2004
8
🐜
🐜 Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.
10 auth. S. Cortese, M. Holtmann, T. Banaschewski, J. Buitelaar, D. Coghill, M. Danckaerts, ... R. Dittmann, John G. I. Graham, E. Taylor, J. Sergeant
8 2013
8
🐜
🐜 Genome‐wide association scan of attention deficit hyperactivity disorder
26 auth. B. Neale, Jessica A Lasky-Su, R. Anney, B. Franke, K. Zhou, J. Maller, A. Vasquez, P. Asherson, Wai Chen, T. Banaschewski, J. Buitelaar, R. Ebstein, M. Gill, A. Miranda, R. Oades, ... H. Roeyers, A. Rothenberger, J. Sergeant, H. Steinhausen, E. Sonuga-Barke, F. Mulas, E. Taylor, N. Laird, C. Lange, M. Daly, S. Faraone
8 2008
8
🐜
🐜 Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
12 auth. D. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, ... Kelly Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, M. Weiss, S. Young
8 2007
8
🐜
🐬 Autism Spectrum Disorders and Schizophrenia: Meta-Analysis of the Neural Correlates of Social Cognition
G. Sugranyes, M. Kyriakopoulos, R. Corrigall, E. Taylor, S. Frangou
8 2011
8
🐬
🐢 Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9–12 years
K. Laurens, S. Hodgins, B. Maughan, R. Murray, M. Rutter, E. Taylor
7 2007
7
🐢
🐢 Long-acting medications for the hyperkinetic disorders
14 auth. T. Banaschewski, D. Coghill, P. Santosh, A. Zuddas, P. Asherson, J. Buitelaar, M. Danckaerts, M. Döpfner, S. Faraone, A. Rothenberger, ... J. Sergeant, H. Steinhausen, E. Sonuga-Barke, E. Taylor
7 2006
7
🐢